PD-1/PD-L1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1/PD-L1, covering 2021-11-10 to 2021-11-10. Get the full timeline:
Most recent: Clinical Trial Update: ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) [Phase 2]